ICC's Brainchild Designed to Show Every Drug and Every Combination a Success. Who Could Complain About That? "It's ddC Monotherapy All Over Again" A hastily organized meeting of the newly formed Inter-Company Collaborative (ICC) was convened April 26 at the…
Accelerated Approval Guidelines Expedite Bristol's Launch of New Nucleoside -- In the Absence of Any Proof That It Works Specter of Fast Track Review Haunts Those Who Spawned It "FDA Panel Recommends Drug Despite Incomplete Data." So read the New…
KS Proves Formidable Foe As Angiogenesis Inhibitors and Stealth Chemotherapy Fall Short of Expectations Pregnant Mice the Key? Michael Marco recently returned from a transcontinental tour of KS research laboratories. While his official report is not due out for another…
One Company's Search for an Effective Antiviral Contrasts Another's Scramble for the Easy Money The Perils & Pains of Integrity Early on a rainy Monday morning, Merck scientists Emilio Emini and John Ryan assembled overheads and flip charts before a…
Study After Study, Antiretroviral Analyses Confound More Than They Clarify Lamenting the Naked Emperor First there was Concorde, the now notorious Anglo-French study which last summer sent shock waves across the Atlantic as it cast doubt on the wisdom of…
TAG and other partner organizations issued this letter about their serious and unresolved concerns about the proposed clinical trial comparing stavudine at 20 mg to tenofovir.
TAG’s annual review of progress we’ve made on the the fight to end HIV/AIDS, Viral Hepatitis, and Tuberculosis.
The exorbitant price of AIDS medicines, especially antiretrovirals, has been one of the main barriers to people with HIV accessing them, especially in developing countries. As activist organisations we have been at the forefront of many of the struggles to make medicines affordable.
A cure for HIV will be an essential part of ending the pandemic. In the past three years, increasing scientific momentum has been evident in research aimed at curing HIV infection (Lehrman 2005; Richman 2009; Trono 2010; Palmer 2011). The…